New (Image 1)
Theophylline Tablet, Extended Release
Product Images NDC 0480-3310
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 0480-3310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
100 (Image 2)
This text provides instructions for storing and dispensing extended-release tablets containing Theophylline. It recommends storing them at room temperature and in a closed container with child-proof safety measures. It also offers information about dosage and manufacturer details.*
100 (Image 3)
NDC 0480-3309-01 is a package of extended-release tablets, containing 450mg Theophylline (Anhydrous) USP. It is manufactured in India by Watson Pharma Private Limited and distributed for Rx only by Teva Pharmaceuticals based in Parsippany, NJ. The medication is usually dosed as indicated in the package insert and should be stored between 68° to 77°F; excursions permitted to 59°F. It should be dispensed in a well-closed container with child-resistant closure as defined in the USP. The package contains 100 tablets with an expiration date of 4/2022. The package has a Serialization Coding Area.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
